ASEC WEBINAR SERIES 1.0
Pharmaceutical Anti-Counterfeiting Measures in the wake of COVID-19
As demand for medical supplies soars worldwide in the fight against COVID-19, there is a parallel risk of substandard and counterfeit medicines in the global market. there is an urgent need to bring in strong anti-counterfeiting measures which will be addressed at ASEC Webinar Series.
“The sale of counterfeit and defective pharmaceuticals is a despicable crime, and the discovery of fake medical supplies related to Covid-19 just as the world pulls together to fight this pandemic makes this global challenge all the more acute and urgent,” said OECD Secretary-General Angel Gurría. “We hope the evidence we have gathered on the value, scope and trends of this illicit trade will help lead to rapid solutions to combat this scourge.”
Missed the Webinar? You can watch it on YouTube Below..
Wednesday, 24th of June, 2020
03:00 PM (Malaysia Time)
2 (Two) Hours
Christoph Stegemann, Director Sales & Business Development
Hazem Ibrahim, Founder & CEO
Asias Security Group Sdn Bhd
Ramesh Raj, Regional Director - Asia Pacific
Pharmaceutical Security Institute
Ruth Lee, Associate Director
United States Pharmacopeia (USP)
Stephen Dunn, Director, Product Security Investigations
Security & Brand Protection with HP
Topic Presentation By:
Regional Solution Architect,
Who Should Attend?
CEOs,CMOs,COOs, Heads of Brand Protection/ Government Affairs/ Regulatory Affairs/ External Affairs/ Anti Illicit Trade Directors / Drug Security/ Anti-Counterfeiting Directors/ Head of Supply Chain & Supply Chain Security, Product Security Managers/ Head of Halal/ Packaging Development Managers/ General Counsel, IP Counsel and Legal Counsels representating Multinational and national brands in the Pharmaceutical Industry.